M6P Therapeutics (Switzerland) GmbH

The company's purpose is to research, develop, manufacture, sell and license products in the fields of biotechnology, medical technology, diagnostics, therapy, pharmacy and related fields. The company may establish branches and subsidiaries in Switzerland and abroad and participate in other companies in Switzerland and abroad. The company may acquire, hold, manage, encumber, exploit and dispose of real estate and intellectual property rights in Switzerland and abroad, as well as finance other companies. The company may provide direct or indirect financing to its direct or indirect subsidiaries and third parties, including its direct or indirect shareholders and their direct or indirect subsidiaries, for its own liabilities and those of other companies (including direct or indirect shareholders of the company or companies in which these shareholders are directly or indirectly involved), provide security of all kinds, including by way of pledges or fiduciary transfers or assignments of the company's assets, or provide guarantees, enter into suretyships or otherwise secure or guarantee the obligations of these other companies, whether for consideration or not. Furthermore, it may engage in liquidity balancing/concentration of net liquidity (cash pooling) with the aforementioned companies or join such a system, including periodic account balancing. All of this may be done by the company without consideration, on preferential terms, without interest, excluding the company's profit motive, and assuming cluster risks. The company may engage in all commercial, financial and other activities that appear to promote the company's purpose or are related to it.